Anyway, it's hard to say what would be truly exces
Post# of 146309
![](/assets/46931549/no_avatar_available_thumb.jpg)
Quote:
Anyway, it's hard to say what would be truly excessive depending on IncellDx's growth projections and what they are spending cash on to get to those targets but it is a much bigger number than I would expect. And of course, Cytodyn is on pace to lose $175 million this year so the streets are filled with blood all around.
But which company has massive potential. I'll take 65+ indications over longhauler assays any day.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)